Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Clinical practice guideline for the assessment and prevention of falls in older people.

BIBLIOGRAPHIC SOURCE(S)

  • National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline for the assessment and prevention of falls in older people. London (UK): National Institute for Clinical Excellence (NICE); 2004 Jun. 185 p.

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Levels of evidence (I-IV) and grading of recommendations (A-D and GPP) are defined at the end of the "Major Recommendations" field.

Case/Risk Identification

C - Older people in the care of healthcare professionals should be asked routinely whether they have fallen in the last year and asked about the frequency, context, and characteristics of the fall.

C - Older people reporting a fall or considered at risk of falling should be observed for balance and gait deficits and considered for their ability to benefit from interventions to improve balance and mobility. (Tests of balance and gait commonly used in the UK are detailed in the original guideline document.)

Multifactorial Falls Risk Assessment

C - Older people who present for medical attention because of a fall, or report recurrent falls in the past year, or demonstrate abnormalities of gait and/or balance should be offered a multifactorial falls assessment of risk. This assessment should be performed by a healthcare professional or professionals with appropriate skills and experience, normally in the setting of a specialist falls service. This assessment should be part of an individualised, multifactorial intervention.

C - Multifactorial assessment may include the following:

  • Identification of falls history
  • Assessment of gait, balance and mobility, and muscle weakness
  • Assessment of osteoporosis risk
  • Assessment of the older person's perceived functional ability and fear relating to falling
  • Assessment of visual impairment
  • Assessment of cognitive impairment and neurological examination
  • Assessment of urinary incontinence
  • Assessment of home hazards
  • Cardiovascular examination and medication review

Multifactorial Interventions

A - All older people with recurrent falls or assessed as being at increased risk of falling should be considered for an individualised multifactorial intervention.

A - In successful multifactorial intervention programmes the following specific components are common (against a background of the general diagnosis and management of causes and recognised risk factors):

  • Strength and balance training
  • Home hazard assessment and intervention
  • Vision assessment and referral
  • Medication review with modification/withdrawal

A - Following treatment for an injurious fall, older people should be offered an assessment to identify and address future risk and individualised intervention aimed at promoting independence and improving physical and psychological function.

Strength and Balance Training

A - Strength and balance training is recommended. Those most likely to benefit are older community-dwelling people with a history of recurrent falls and/or balance and gait deficit. A muscle strengthening and balance programme should be offered. This should be individually prescribed and monitored by an appropriately trained professional.

Exercise in Extended Care Settings

A - Multifactorial interventions with an exercise component are recommended for older people in extended care settings who are at risk of falling.

Home Hazard and Safety Intervention

A - Older people discharged from hospital following a fall should be offered a home hazard assessment and safety intervention/modifications by a suitably trained healthcare professional. This should normally be part of discharge planning and be carried out within a timescale agreed by the patient or carer and appropriate members of the healthcare team.

A - Home hazard assessment is shown to be effective only in conjunction with follow-up and intervention, not in isolation.

Psychotropic Medications

B - Older people on psychotropic medications should have their medication reviewed, with specialist input if appropriate, and discontinued if possible to reduce their risk of falling.

Cardiac Pacing

B - Cardiac pacing should be considered for older people with cardioinhibitory carotid sinus hypersensitivity who have experienced unexplained falls.

Encouraging the Participation of Older People in Falls Prevention

D - To promote the participation of older people in falls prevention programmes the following should be considered:

  • Healthcare professionals involved in the assessment and prevention of falls discussing which changes a person is willing to make to prevent falls.
  • Information should be relevant and available in languages other than English.
  • Falls prevention programmes should also address potential barriers such as low self-efficacy and fear of falling and encourage activity change as negotiated with the participant.

D - Practitioners who are involved in developing falls prevention programmes should ensure that such programmes are flexible enough to accommodate participants' different needs and preferences and should promote the social value of such programmes.

Education and Information Giving

D - Healthcare professionals involved in falls prevention should be educated about falls assessment and prevention.

D - Individuals at risk of falling and their carers should be offered information orally and in writing about:

  • What measures they can take to prevent further falls
  • How to stay motivated if referred for falls prevention strategies that include exercise or strength and balancing components
  • The preventable nature of some falls
  • The physical and psychological benefits of modifying falls risk
  • Where they can seek further advice and assistance
  • How to cope if they have a fall, including how to summon help and how to avoid a long lie

Definitions:

Evidence Categories

I: Evidence from meta-analysis of randomised controlled trials or at least one randomised controlled trial

II: Evidence from at least one controlled trial without randomization or at least one other type of quasi-experimental study

III: Evidence from non-experimental descriptive studies, such as comparative studies, correlation studies, and case–control studies

IV: Evidence from expert committee reports or opinions and/or clinical experience of respected authorities

Recommendation Grades

Grade A - Directly based on category I evidence

Grade B - Directly based on category II evidence or extrapolated recommendation from category I evidence

Grade C - Directly based on category III evidence or extrapolated recommendation from category I or II evidence

Grade D - Directly based on category IV evidence or extrapolated recommendation from category I, II, or III evidence

Good Practice Point (GPP) - Recommended good practice based on the clinical experience of the Guideline Development Group (GDG)

CLINICAL ALGORITHM(S)

A clinical algorithm is provided in a companion document for "Patient Referral and Care Pathway." See "Availability of Companion Documents" field.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline for the assessment and prevention of falls in older people. London (UK): National Institute for Clinical Excellence (NICE); 2004 Jun. 185 p.

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2004 Jun

GUIDELINE DEVELOPER(S)

National Collaborating Centre for Nursing and Supportive Care - National Government Agency [Non-U.S.]

SOURCE(S) OF FUNDING

National Institute for Clinical Excellence (NICE)

GUIDELINE COMMITTEE

Guideline Development Group

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Guideline Development Group Members: Professor Gene Feder (Group leader) Department of General Practice & Primary Care, St Bartholomew's and the London Queen Mary's School of Medicine and Dentistry; Miss Margaret Clark, Alzheimer's Society; Dr Jacqueline Close, Royal College of Physicians, King's College Hospital, London; Dr Colin Cryer, Centre for Health Services Studies, University of Kent at Canterbury; Ms Carolyn Czoski-Murray, School of Health and Related Research, University of Sheffield; Mr David Green, Royal Pharmaceutical Society of Great Britain. The Pharmacy, Colchester Hospital; Dr Steve Illiffe, Royal College of General Practitioners, Department of Primary Care & Population Sciences, Royal Free Hospital; Professor Rose Anne Kenny, Institute for Health of the Elderly, University of Newcastle upon Tyne; Dr Chris McCabe, School of Health and Related Research, University of Sheffield; Mrs Eileen Mitchell, Clinical Effectiveness Forum for Allied Health Professionals, North Dorset Primary Care Trust; Dr Sarah Mitchell, Clinical Effectiveness Forum for Allied Health Professionals, Glasgow Royal Infirmary; Dr Peter Overstall, British Geriatrics Society. County Hospital, Hereford; Mrs Mary Preddy, National Osteoporosis Society; Professor Cameron Swift, King's College Hospital (Link Guideline Development Group member for the Osteoporosis Guideline); Mrs Deidre Wild, Royal College of Nursing

National Collaborating Centre for Nursing and Supportive Care: Ms Sue Boyt, Administrator; Ms Jacqueline Chandler-Oatts, Research Associate; Ms Elizabeth Gibbons, Research and Development Fellow; Dr Gill Harvey, Director; Ms Jo Hunter, Information Specialist; Ms Elizabeth McInnes, Senior Research and Development Fellow; Ms Emma Nawrocki, Administrator; Mr Robin Snowball, Information Specialist (seconded from Cairns Library, John Radcliffe Hospital, Oxford); Mr Edward Weir, Centre Manager

Additional assistance: Dr Phil Alderson, Cochrane Centre, UK; Dr Lesley Gillespie, Cochrane, Musculo-skeletal injuries group, UK; Dr Lesley Smith, Centre for Statistics in Medicine

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

All members of the Guideline Development Group (GDG) were required to make formal declarations of interest at the outset, which were recorded. GDG members were also asked to declare interests at the beginning of each GDG meeting. This information is recorded in the meeting minutes and kept on file at the National Collaborating Centre for Nursing and Supportive Care (NCC-NSC).

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the National Institute for Clinical Excellence (NICE) Web site.

Print copies: Available from the National Health Service (NHS) Response Line 0870 1555 455, ref: N0247. 11 Strand, London, WC2N 5HR.

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

Additionally, Audit Criteria can be found in Section 8 of the original guideline document.

PATIENT RESOURCES

The following is available:

Print copies: Available from the National Health Service (NHS) Response Line 0870 1555 455, ref N0761.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI on February 16, 2005. The information was verified by the guideline developer on March 7, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo